salsolinol has been researched along with selegiline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dostert, P; Strolin Benedetti, M | 1 |
| Deng, Y; Dostert, P; Maruyama, W; Naoi, M; Takahashi, T; Zhang, JH | 1 |
| Griffiths, HR; Lambert, DG; Lunec, J; Willets, JM | 1 |
1 review(s) available for salsolinol and selegiline
| Article | Year |
|---|---|
Overview of the present state of MAO inhibitors.
Topics: Animals; Benzamides; Humans; Hydrazines; Isoquinolines; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Parkinson Disease; Phenethylamines; Piperidines; Selegiline; Structure-Activity Relationship | 1987 |
2 other study(ies) available for salsolinol and selegiline
| Article | Year |
|---|---|
Enzymatic oxidation of the dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion.
Topics: Cell Compartmentation; Cerebral Cortex; Clorgyline; Humans; In Vitro Techniques; Isoquinolines; Kinetics; Neurotoxins; Oxidation-Reduction; Selegiline; Semicarbazides | 1995 |
Studies on the neurotoxicity of 6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in SH-SY5Y cells.
Topics: Adenylyl Cyclases; Adrenergic Uptake Inhibitors; Catecholamines; Cell Death; Clorgyline; Dose-Response Relationship, Drug; Guanylate Cyclase; Humans; Imipramine; Indoles; Isoquinolines; L-Lactate Dehydrogenase; Monoamine Oxidase Inhibitors; Neuroblastoma; Neurotoxins; Nitroprusside; Receptors, Muscarinic; Selegiline; Tumor Cells, Cultured | 1995 |